AIMD logo

AIMD Ainos, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$1.18
+0.07 (+6.31%)

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic…

Market Cap: $8.93Mwww.ainos.com

Price

No data yet.

Social Signal Score

42
5d
—
30d
—
60d
39
4 mentions
—
90d
44
7 mentions
—
news: 7

Revenue

$642.9K
$-4.4K$583.0K$1.17M$1.76M
Dec 2016Sep 2026

Company Profile

CEO
Chun-Hsien Tsai
Sector
Healthcare
Industry
Biotechnology
Employees
41
Beta
2.69
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-8.72
www.ainos.com